Authors
Latest:
Prognostic Value of Low Tumor Burden in Patients With MelanomaIn this article, we review the role of baseline tumor size in response and survival on traditional and contemporary therapies for the treatment of locoregional and distant melanoma recurrences.
Latest:
The Diagnosis and Management of Retroperitoneal SarcomaRetroperitoneal sarcoma is a rare tumor whose diagnosis and management can be challenging and for which management requires a multidisciplinary team.
Latest:
Eric Ko on Combining Radiation Therapy With Immunotherapy to Treat Non–Small-Cell Lung CancerONCOLOGY spoke with Eric Ko, MD, PhD, who recently published a review article with his colleagues on strategies for combining radiation therapy with immunotherapy for the treatment of non–small-cell lung cancer.
Latest:
POINT: Should Radiation Therapy Be Routinely Used in the Adjuvant Treatment of Stage III Endometrial Cancer?Adjuvant radiation therapy provides a local control benefit in stage III endometrial carcinoma patients, as strongly suggested in retrospective and prospective series.
Latest:
POINT: Should Radiation Therapy Be Routinely Used in the Adjuvant Treatment of Stage III Endometrial Cancer?Adjuvant radiation therapy provides a local control benefit in stage III endometrial carcinoma patients, as strongly suggested in retrospective and prospective series.
Latest:
COUNTERPOINT: Should Radiation Therapy Be Routinely Used in the Adjuvant Treatment of Stage III Endometrial Cancer?The routine use of adjuvant radiation therapy in stage III endometrial cancer patients is not supported by the current literature and should not be employed universally in this group of patients.
Latest:
CRESTONE Trial of Seribantumab in Solid Tumors With NRG1 Fusions: Real-World ImplicationsLooking toward the future management of solid tumors with NRG1 fusions, expert panelists consider how the availability of seribantumab therapy may impact their practice.
Latest:
Alpelisib Is Changing the Clinical Landscape in Breast Cancer TreatmentThe US Food and Drug Administration recently approved alpelisib plus fulvestrant for the treatment of metastatic or otherwise advanced breast cancer.
Latest:
Population Testing to Prevent Gynecologic CancersDr. Ranjit Manchanda speaks with Cancer Network about using population testing to predict and prevent gynecologic cancers.
Latest:
Holistic Cancer Therapy and Symptom ManagementProfessor Judi Fouladbakhsh speaks with Cancer Network about evidence-based holistic approaches to cancer care.
Latest:
Managing Psychosocial Distress: Lessons Learned in Optimizing Screening Program ImplementationThis article discusses “lessons learned” on managing psychosocial distress and the optimal strategies to promote institutions’ adoption of distress screening.
Latest:
Managing Psychosocial Distress: Lessons Learned in Optimizing Screening Program ImplementationThis article discusses “lessons learned” on managing psychosocial distress and the optimal strategies to promote institutions’ adoption of distress screening.
Latest:
Managing Psychosocial Distress: Lessons Learned in Optimizing Screening Program ImplementationThis article discusses “lessons learned” on managing psychosocial distress and the optimal strategies to promote institutions’ adoption of distress screening.
Latest:
Managing Psychosocial Distress: Lessons Learned in Optimizing Screening Program ImplementationThis article discusses “lessons learned” on managing psychosocial distress and the optimal strategies to promote institutions’ adoption of distress screening.
Latest:
Managing Psychosocial Distress: Lessons Learned in Optimizing Screening Program ImplementationThis article discusses “lessons learned” on managing psychosocial distress and the optimal strategies to promote institutions’ adoption of distress screening.
Latest:
When to Order an MRI in the Initial Evaluation and Management of Prostate CancerThis article summarizes the current role of multiparametric MRI in the diagnosis, risk assessment, and treatment of prostate cancer.
Latest:
When to Order an MRI in the Initial Evaluation and Management of Prostate CancerThis article summarizes the current role of multiparametric MRI in the diagnosis, risk assessment, and treatment of prostate cancer.
Latest:
Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast CancerAn otherwise healthy 58-year-old woman with a history of breast cancer presents to the clinic with newly diagnosed metastatic disease; eventual abdominal CT showed a mass in the transverse colon with ascites and peritoneal nodularity. What is the best initial systemic treatment for her?
Latest:
Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast CancerAn otherwise healthy 58-year-old woman with a history of breast cancer presents to the clinic with newly diagnosed metastatic disease; eventual abdominal CT showed a mass in the transverse colon with ascites and peritoneal nodularity. What is the best initial systemic treatment for her?
Latest:
Herb-Drug Interactions in Cancer CareIn this article, we describe the mechanisms via which interactions between herbs and prescription drugs may occur, and highlight four popular herbs and a medicinal mushroom commonly used by cancer patients, along with reports of their interactions with standard drugs.
Latest:
A Patient With EGFR-Mutated Lung Cancer Progressing on Erlotinib: Evaluating for a T790M Mutation With Limited TissueDue to the high rate of EGFR T790M mutations seen in NSCLC patients, the thoracic tumor board recommends genomic testing for this alteration; read our case of a 69-year-old woman with metastatic disease.
Latest:
A Patient With EGFR-Mutated Lung Cancer Progressing on Erlotinib: Evaluating for a T790M Mutation With Limited TissueDue to the high rate of EGFR T790M mutations seen in NSCLC patients, the thoracic tumor board recommends genomic testing for this alteration; read our case of a 69-year-old woman with metastatic disease.
Latest:
A Patient With EGFR-Mutated Lung Cancer Progressing on Erlotinib: Evaluating for a T790M Mutation With Limited TissueDue to the high rate of EGFR T790M mutations seen in NSCLC patients, the thoracic tumor board recommends genomic testing for this alteration; read our case of a 69-year-old woman with metastatic disease.
Latest:
Dual HER2-Targeting in the Adjuvant Setting: Where We Have Been and Where We Are GoingThis article discusses the advances in HER2-targeted therapy, in both the metastatic and adjuvant settings, with a focus on those with early-stage breast cancer.
Latest:
Integrating Immunotherapy Into Colorectal Cancer CareUntil recent studies were reported, immunotherapy was thought to be ineffective for colorectal cancer; this article provides guidance on how to incorporate immunotherapy into this setting.
Latest:
Recognizing the Side Effects of Newly Approved CLL TherapiesDr. Ian Flinn spoke with Cancer Network about incorporating the newest approved therapies for the management of CLL.
Latest:
Using Exosomes to Help Cancer DiagnosisDr. Raghu Kalluri speaks with Cancer Network about the role of exosomes in cancer progression ahead of his presentation at ESMO 2018.
Latest:
FDA Approves Two New Indications and Dosage Form for PembrolizumabIn this installment of Oncology Drug Updates, updates to FDA approvals for pembrolizumab in the treatment of lung cancer and RCC are highlighted.
Latest:
Managing Anxiety and Depression in Cancer PatientsDr. William Pirl speaks with Cancer Network about cancer patients' moods influencing their well-being and survival.
Latest:
2019 World Conference Of Lung Cancer Round-UpFive notable abstracts from the 2019 World Conference on Lung Cancer (WCLC).
